Skip to content

Tag: Mgd

Explore our medication guides and pharmacology articles within this category.

Is Cationorm better than Systane? A 2025 Pharmacological Review

4 min read
The prevalence of dry eye disease is estimated to be between 5% and 50% of the population worldwide, making the choice of artificial tears critical [1.6.1]. The question of whether **Is Cationorm better than Systane?** depends heavily on an individual's specific condition and the underlying cause of their symptoms.

What is the new drug for blepharitis?

4 min read
Affecting an estimated 25 million people in the U.S., or one in every 12 adults, Demodex blepharitis has historically been a challenging condition to treat [1.2.2, 1.3.4]. So, **what is the new drug for blepharitis?** A major breakthrough is Xdemvy (lotilaner), the first and only FDA-approved therapy that directly targets the cause [1.2.5, 1.3.1].

How long does it take to see results from Miebo?

4 min read
Clinical studies show some patients experience symptom relief within just 5 to 60 minutes after the first application of Miebo, marking a surprisingly rapid start to the treatment process. However, this is just the beginning of the journey, so how long does it take to see results from Miebo for significant and sustained improvement?

Can you use Miebo long term? A Guide to Safety and Efficacy

4 min read
Dry eye disease (DED) affects more than 38 million Americans, with the majority of cases linked to excessive tear evaporation. For those seeking lasting relief, a key question is: **can you use Miebo long term** for this chronic condition? Clinical data provides promising answers.